))
TWiPO #64 - Interview with Dr. Lars Wagner
Archived series ("iTunes Redirect" status)
Replaced by: This Week in Pediatric Oncology
When?
This feed was archived on December 27, 2017 07:50 (
Why? iTunes Redirect status. The feed contained an iTunes new feed tag.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 183004277 series 1182803
Content provided by Solving Kids' Cancer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Solving Kids' Cancer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
It’s an exciting time to be part of the childhood cancer research community, and this interview was focused on career advice for those interested in childhood oncology and research. The availability of genomic profiling of tumors, targeted agents and the development of new immunotherapies are increasing the opportunities available to patients today. This lively discussion addresses the importance of preclinical data, predictive biomarker studies and the measurement of responses, with specific references to Dr. Wagner’s experience with studying irinotecan. Dr. Wagner also answered questions about radiomics and how this imaging trend can provide more insights for enhanced radiology reporting.
Please send questions and comments to TWiPO@solvingkidscancer.org
71 episodes
Share
